Cerebral mucormycosis in a diabetic man

Connecticut Medicine

Volumn 75, Issue 5, 2011, Pages 273-279

  Maeuy, Edilfavia ^a   Rustagi, Tarun ^a   Khera, Surendra ^b  

^a SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; POSACONAZOLE; TRIAZOLE DERIVATIVE;

ARTICLE; BIOPSY; BRAIN DISEASE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG COMBINATION; ENDOSCOPY; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; MUCORMYCOSIS; MULTIMODALITY CANCER THERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; BIOPSY; BRAIN DISEASES; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; ENDOSCOPY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUCORMYCOSIS; TOMOGRAPHY, X-RAY COMPUTED; TRIAZOLES;

EID: 79957866842     PISSN: 00106178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Kauffman CA.Malani AN: Zygomycosis: An emerging fungal infection with new options for management. Curr Infect Dis Rep Nov 2007; 9(6):435-40. (Pubitemid 350081423)
2. Baker RD: The phycomycoses. Ann N Y Acad Sci Oct 1970; 174(2):592-605.
3. Roden MM, Zaoutis TE, Buchanan WL, et al: Epidemiology and outcome of zygomycosis: A review of 929 reported cases. Clin Infect Dis Sep 2005; 41(5):634-53. (Pubitemid 41170352)
4. McNulty JS: Rhinocerebral mucormycosis: Predisposing factors. Laryngoscope Oct 1982; 92(10):1140-3.
5. Lee FY, Mossad SB, Adal KA: Pulmonary mucormycosis: Thehst 30 yeais.Arch Intern Med Jun 1999; 159(12): 1301-9.
6. Ismail MH, Hodkinson HJ, Setzen G, et al: Gastric mucormycosis. Trop Gastroenterol Apr-Jun 1990; 11(2):103-5.
7. Adam RD, Hunter G, DiTomasso J, et al: Mucormycosis: Emerging prominence of cutaneous infections. Clin Infect Dis Jul 1994; 19(1):67-76. (Pubitemid 24227037)
8. Cocanour CS. Miller-Crotchett P, Reed RL 2nd, et al:Mucormycosis in trauma patients. J Trauma Jan 1992; 32(1):12-15.
9. Levy E, Bia MJ: Isolated renal mucormycosis: Case report and review. J Am Soc Nephrol Jun 1995; 5(12):2014-9.
10. Nagy-Agren SE, Chu P, Smith GJ, et al: Zygomycosis and HIV infection: Report of three cases and review. J Aquir Immune Defic Syndr Hum Retroviral Dec 1995; 10(4):441-9.
11. Kontoyiannis DP, Wessel VC, Bodey GP, et al: Zygomycosis in the 1990s in a tertiary care cancer center. Clin Infect Dis Jun 2000; 30(6):851-6. (Pubitemid 32250321)
12. Marr KA, Carter RA, Crippa F, et al: Epidemiology and outcome of mould infections in hematopoetic stem cell transplant recipients. Clin Infect Dis Apr 2002; 34(7):909-17. (Pubitemid 34229758)
13. Han SR,Choi CY, Joo M, et al: Isolated cerebral mucormycosis. J Korean Neurosurg Soc Nov 2007; 42(5):400-2. (Pubitemid 350303470)
14. Cheema SA, Amin F: Five cases of rhinocerebral mucormycosis. BrJ Oral maxillofac Surg Mar 2007; 45(2):161-2. (Pubitemid 46131984)
15. Metellus P, Laghmari M, Fuentes S, et al; Successful treatment of a giant isolated cerebral mucormycotic (zygomycotic) abscess using endoscopic debridement: Case report and therapeutic considerations. Surg Neurol May 2008; 69(5):510-5. (Pubitemid 351522285)
16. Stave GM, Heimberger T, Kerkering TM: Zygomycosis of the basal ganglia in intravenous drug users. Am J Med Jan 1989; 86(1):115-7. (Pubitemid 19039548)
17. Siddiqi SU, Freedman JD: Isolated central nervous system mucormycosis. South Med J Oct 1994; 87(10):997-1000. (Pubitemid 24312011)
18. Weprin BE, Hall WA, Goodman J, et al: Long-term survival in rhinocerebral mucormycosis: Case report. J Neurosurg Mar 1998; 88(3):570-5. (Pubitemid 28114733)
19. Fong KM, Seneviratne EM, McCormack JG: Mucor cerebral abscess associated with intravenous drug abuse. Aust N ZJ Med Feb 1990; 20(1):74-7. (Pubitemid 20344593)
20. Gaing AA, Corbalan F, Weinberger J: Phycomycosis (mucormycosis) in differential diagnosis of cerebral mass lesions in intravenous drugusers.Mt Sinai J Med Jan 1992;59(1):69-71.
21. Hopkins RJ, Rothman M, Fiore A, et al: Cerebral mucormycosis associated with intravenous drug use: Three case reports and review. Clin Infect Dis Dec 1994; 19(6):1133-7. (Pubitemid 24380030)
22. Nussbaum ES, Hall WA: Rhinocerebral mucormycosis: Changing patterns of disease. Surg Neurol Feb 1994; 41(2):152-6. (Pubitemid 24158876)
23. Terk MR, Underwood DJ, Zee CS, et al: MR imaging in rhinocerebral and intracranial mucormycosis with CT and pathologic correhtion. Magn Reson Imaging 1992; 10(1):81-7.
24. Cook BA, White CB, Blaney SM, et al: Survival after cerebral mucormycosis. Am J Pediatr Hematol Oncol 1989 Fall; 11(3):330-3.
25. Verma A, Brozman B, Petito CK: Isolated cerebral mucormycosis: Report of a case and review of the literature. J Neurol Sci 2006 Jan; 240(1-2):65-9. (Pubitemid 41814955)
26. Ruoppi P, Dietz A, Nikanne E, et al: Paranasal sinus mucormycosis: A report of two cases. Acta Otolaryngol Dec 2001; 121(8):948-52. (Pubitemid 34086934)
27. Parizel P, Phillips C: Neuroradiological diagnosis of craniocerebral trauma: Current concepts. Disease of the Brain, Head and Neck, Spine, Diagnostic Imaging and Interventional Technique. 2008; Part 1,65-73.
28. Haliloglu NU, Yesilirmak Z, Erden A et al: Rhino-orbitocerebral mucormycosis: Report of two cases and review of the literature. Dentomaxillofacial Radiol Mzy 2008; 37:161-6. (Pubitemid 351450161)
29. Gupta A, Kalsotra G: Rhinocerebral Mycosis: Combined Modality Protocol. Otorhinolaryngology Clinics: An International Journal. Sept-Dec 2009;1(1):49-54.
30. Spellberg B, Walsh TJ, Kontoyiannis DP, et al: Recent advances in the management of mucormycosis: From bench to bedside. Clin Infect Dis Jun 2009; 48(12):1743-51.
31. Adler DE, Milhorat TH, Miller JI: Treatment of rhinocerebral mucormycosis with intravenous interstitial, and cerebrospinal fluid administration of amphotericin B: Case report. Neurosurgery Mar 1998; 42(3):644-8.
32. Chick EW, Evans J, Baker RD: Treatment of mucormycosis in rabbits with amphotericin B. Antibiot Chemother 1958; 8:394-7.
33. Wilson WB, GrottaJC, Schold C, et al: Cerebral mucormycosis: An unusual case. Arch Neurol Nov 1979; 36(11):725-6.
34. Spanakis EK, Aperis G, Mylonakis E: New agents for the treatment of fungal infections: Clinical efficacy and gaps in coverage. Clin Infect Dis Oct 2006; 43(8):1060-8. (Pubitemid 44631109)
35. Sun QN, Fothergill AW, McCarthy DI, et al: In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes. Antimicrob Agents Chemother May 2002; 46(5):1581-2. (Pubitemid 34415351)
36. Van Burik JA, Hare RS, Solomon HF, et al: Posaconazole is effective as salvage therapy in zygomycosis: A retrospective summary of 91 cases. Clin Infect Dis Apr 2006; 42(7):e61-5.